Atrial Imaging and Cardiac Rhythm In Embolic Stroke
ARIES
1 other identifier
observational
150
1 country
1
Brief Summary
The ARIES study is an observational study in which patients with a recent acute ischemic stroke of cryptogenic aetiology are consecutively enrolled in order to perform a extensive cardiologic work-up. The main objective is to study parameters that could predict arrythmias on prolonged monitoring and also echocardiographic parameters of left atrial disfunction that could predict the presence of a hidden atrial fibrilation and recurrent ischemic events in patients with cryptogenic stroke.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 17, 2020
CompletedFirst Submitted
Initial submission to the registry
August 2, 2022
CompletedFirst Posted
Study publicly available on registry
August 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedAugust 3, 2022
May 1, 2022
2 years
August 2, 2022
August 2, 2022
Conditions
Outcome Measures
Primary Outcomes (5)
Analyze frequency of parafibrilatory status in cryptogenic stroke patients
Analyze the frequency of parafibrilatory status defined as \> 3000 atrial ectopic beats per day or more or \>2 "micro-AF" episodes per day (fibrillatory burst \<30 seconds without a monomorphic P wave ) on 30 day ECG monitoring
30 days
Analyze frequency of ecocardiographic parameters of atrial disfunction
Dimensions and function of left atrium, telesystolic volume, left auricular ejection fraction, atrial longitudinal strain in 3 phases (reservoir, conduict, contractile)
During hospitalization
Frequency of detection of atrial fibrilation
Frequency of detection of atrial fibrilation lasting for more than 30 seconds on two 30 day ECG monitoring.
60 days
Correlation of parafibrilatory state and echocardiographic parameters of atrial disfunction with the probability of detection of atrial fibrilation.
Correlation of parafibrilatory state and echocardiographic parameters of atrial disfunction with the probability of detection of atrial fibrilation of more than 30 seconds of duration in 30-day ECG monitoring.
30 days
Correlation of parafibrilatory state and echocardiographic parameters of atrial disfunction with the probability of stroke recurrence.
Correlation of parafibrilatory state and echocardiographic parameters of atrial disfunction with the probability of stroke recurrence in patients without documented atrial fibrilation.
At 3 months and 1 year.
Study Arms (1)
Cryptogenic stroke patients
Patients with an acute ischemic stroke of cryptogenic origin with a previous negative work-up that includes: blood analysis, brain CT / MRI, angio-TC / angio-MRI, brain vessel ultrasound, ECG, 24h ECG-holter, echocardiography).
Interventions
Specific 3D and 2D echocardiography measuring left ventricule and left atrial dimensions as well as longitudinal strain. 30 day prolonged ECG monitoring.
Eligibility Criteria
Patients older than 50 years old addmitted to the neurology ward in La Paz University Hospital with a recent diagnosis of cryptogenic ischemic stroke.
You may qualify if:
- Patients addmitted to the Neurology service at La Paz University Hospital with a recent diagnosis of cryptogenic stroke considered non-lacunar and where no other reasonable diagnosis is suspected.
- Signed informed consent.
You may not qualify if:
- Presence of large vessel atheromatosis with \>50% estenosis, or \<50% but with two or more vascular risk factors (age \> 50 years old, hipertension, diabetes mellitus, dyslipidemia, smoker).
- Patients with a un favorable clinical situation or dependance who will not benefit from the study or those that could not fullfill study visits and procedures.
- Patients in which an embolic arrythmia has already been demonstrated
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
La Paz University Hospital
Madrid, 28046, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ricardo Rigual Bobillo, MD
Hospital Universitario La Paz
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 2, 2022
First Posted
August 3, 2022
Study Start
December 17, 2020
Primary Completion
December 31, 2022
Study Completion
December 31, 2022
Last Updated
August 3, 2022
Record last verified: 2022-05